Skip to main content

Professor Juliet Gray

Professor Juliet Gray is a consultant in paediatric oncology.


Training and education

  • Queens’ College, Cambridge, Medical Sciences Tripos (MA)
  • Royal Free Hospital, University of London (MB BS)
  • PhD in cancer immunotherapy (University of Southampton)


Professor Gray was appointed as a consultant in Paediatric Oncology at University Hospital Southampton NHS Foundation Trust in 2010. She is also a Professor at the University of Southampton in the Centre for Cancer Immunology. She completed her clinical paediatric oncology training at Great Ormond Street Hospital, the Royal Marsden Hospital and Southampton University NHS Foundation Trust. During her training, she also undertook a Cancer Research UK Clinical Research Fellowship and NIHR Clinical Lectureship at the University of Southampton.

Professor Gray looks after children with all types of malignancy but has a specific clinical and research interest in neuroblastoma and cancer immunotherapy. She leads a number of national and international neuroblastoma clinical trials and also oversees a laboratory research group focused on novel immunotherapies for children’s cancers.

Trust roles:

  • Clinical lead Southampton paediatric oncology and haematology service
  • Clinical lead Wessex Children’s Cancer Network
  • Clinical lead Thames Valley-Wessex Operational Delivery Network
  • Sub-speciality (Paediatric Oncology) lead Wessex Clinical Research Network
  • Centre lead Paediatric Experimental Cancer Medicine Centre (ECMC)

National and international roles:

  • NCRI Children’s Group Neuroblastoma subgroup – chair
  • NCRI Children’s Group – member
  • NCRI Children’s Group Novel Agents subgroup – member
  • UK National Neuroblastoma Advisory Panel – member
  • Experimental Cancer Medicine Centre (ECMC) – member of Paediatric Strategy Group and co-lead for Immunotherapy theme
  • European Neuroblastoma Research Network (SIOPEN) – chair of Clinical Trials Committee, co-chair Immunotherapy Committee, member of Finance Steering Committee, member of Translational Steering Committee
  • Cancer Research UK, member of Protocol Safety Review Board
  • Member of scientific advisory boards for a number of charities (Solving Kids Cancer, Neuroblastoma Australia, Friends of Rosie)
  • Member of scientific advisory board for Precision Oncology Ireland
  • University of Nottingham - external examiner MSc Cancer Immunotherapy and Biotechnology


Professor Gray’s main research focus is in developing new immunotherapies for paediatric cancers such as neuroblastoma. She leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials.

Click here to see more of Juliet Gray's previous research.


Secretary: Lorraine Davidson call 023 8120 4101